Afterward, we used 8‐month‐old APP/PS1 Tg mice which have the mutated human APPs we and PSEN1ΔE9, to examine the therapeutic efficacy of thioperamide, a H3R antagonist in AD. This evidence concerns the gene HRH3 and Alzheimer disease.